Opvee®, a recently approved nasal spray for opioid overdose reversal, offers a faster and longer-lasting alternative to Narcan®, but experts warn its focus on synthetic opioids such as fentanyl and outdated data could mask potential drawbacks.

A growing body of research shows getting little or poor sleep doesn’t just make people feel tired the next day – it places them at higher risk for heart attacks and early death, along with cognitive decline, dementia, diabetes, high blood pressure, obesity, depression and other chronic health conditions.

Spencer Willis Jr., DrPH, associate professor of practice at the Mel and Enid Zuckerman College of Public Health, co-authors an article about helping educators from diverse institutions boost career readiness by presenting various strategies that suit different comfort levels and degrees of engagement.

The Food and Drug Administration has approved pembrolizumab, an anti-programmed death receptor-1 therapy, plus chemoradiotherapy, to treat individuals with International Federation of Gynecology and Obstetrics 2014 stage III-IVA cervical cancer.

New Nursing dean says technology, including AI, will enhance research and education to reach even more of those in need of care.

Before we get too far into 2024, I’d like to share with you one of our final projects of 2023, the inaugural Health Sciences Impact Annual Report.

Stephenson named one of top 50 women leaders in medicine

Arizona Center for Rural Health

Mel and Enid Zuckerman College of Public Health